RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40519166.
- Also identified by DOI 10.1172/JCI185119 and PMC identifier 12165809.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Castration-resistant prostate cancer (CRPC) marks the advanced and lethal stage of prostate cancer (PCa). TRIM28, also known as KAP1, is a transcriptional regulator recently shown to promote CRPC cell proliferation and xenograft tumor growth. Nonetheless, knowledge gaps persist regarding the mechanisms underlying TRIM28 upregulation in CRPC as well as the genomic targets regulated by TRIM28. Here, we report that TRIM28 is a E2F1 target in CRPC. Using an integrated genomic approach, we have demonstrated that TRIM28 forms a positive feedback loop to promote the transcriptional activation and genomic function of E2F1 independent of retinoblastoma (Rb) status. Furthermore, we identified RSK1 as a kinase that directly phosphorylates TRIM28 at S473, and, as such, RSK1 drives the TRIM28/E2F1 feedback loop. Accordingly, pS473-TRIM28 promotes CRPC progression, which is mitigated by RSK inhibition. In summary, our study reveals a critical role of the RSK1-TRIM28-E2F1 axis in CRPC progression, which may be exploited as a vulnerability in treating Rb-deficient CRPC.
Medical subject headings
- E2F1 Transcription Factor
- Ribosomal Protein S6 Kinases, 90-kDa
- Tripartite Motif-Containing Protein 28
- Prostatic Neoplasms, Castration-Resistant
- Feedback, Physiological
- Neoplasm Proteins